Please login to the form below

Not currently logged in
Email:
Password:

biologics

This page shows the latest biologics news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai announce FDA submission for early Alzheimer’s treatment

Biogen and Eisai announce FDA submission for early Alzheimer’s treatment

Biogen and Eisai have announced the rolling submission to the US Food and Drug Administration (FDA) for a Biologics License Application (BLA) for lecanemab.

Latest news

More from news
Approximately 22 fully matching, plus 661 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 5 fully matching, plus 89 partially matching documents found.

Latest appointments

More from appointments
Approximately 8 fully matching, plus 48 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 7 fully matching, plus 41 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...